COMMUNIQUÉS West-GlobeNewswire

Half-Year Report on Liquidity Contract with Invest Securities
08/07/2026
NANTES, France, July 8, 2026 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following resources [...]
Nordic Ranked No. 1 Overall in Black Book’s 2026 Healthcare IT Consulting and Advisory Services Report
08/07/2026
MADISON, Wis., July 08, 2026 (GLOBE NEWSWIRE) -- Nordic ® , a global health and technology consulting company, has been ranked No. 1 overall in Black Book Market Research's 2026 Healthcare IT Consulting & Advisory [...]
GumiTide Official Announces 2026 In The USA & Canada New Advanced Formula Gumitide Gummies For Weight Loss in Markets
08/07/2026
Discover Gumitide Gummies, a natural dietary supplement designed to support metabolism, appetite control, and healthy weight management. Made in the USA with quality ingredients like apple cider vinegar and BHB mineral [...]
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
08/07/2026
90.5% interim disease control rate (DCR) observed with combination therapy Initial Part C efficacy observations align with previously reported THIO-101 clinical activity despite a more heavily pre-treated patient [...]
NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh
08/07/2026
Boca Raton, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. (“NOMAD” or the “Company”) (Nasdaq: NMAD), through its wholly owned subsidiary, Nomad Transportable Power Systems Inc., today announced the [...]
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
08/07/2026
Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. VANCOUVER, British Columbia, July 08, 2026 (GLOBE NEWSWIRE) -- Cannabix [...]
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
08/07/2026
-- Arbitration tribunal declared that PM647 is within Prime Medicine’s “Field”, confirming Prime Medicine’s right to develop and commercialize PM647 in AATD -- -- Prime Medicine owes no monetary damages to Beam [...]
Polomar Health Services Strengthens Board Leadership to Support Standalone Growth Strategy
08/07/2026
Hornig Appointed Executive Chairman; Caruolo Appointed Lead Independent Director PALM HARBOR, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: PMHS) (“Polomar” or the “Company”), a [...]
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
08/07/2026
Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “ [...]
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
08/07/2026
RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel [...]
International Gastroenterology Expert Working Group Publishes Consensus Framework for Improved Classification of Gastric Function in Patients with Chronic Stomach Conditions
08/07/2026
Neurogastroenterology & Motility paper describes the Auckland Classification, which is designed to bring clinical clarity to the hundreds of millions of patients worldwide The Auckland Classification, developed with [...]
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08/07/2026
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027 Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-label [...]
Cannara Biotech Inc. annoncera ses résultats financiers pour le troisième trimestre de l'exercice 2026 le 15 juillet 2026
08/07/2026
MONTRÉAL, 08 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0) , producteur verticalement intégré de cannabis [...]
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
08/07/2026
MONTREAL, July 08, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
08/07/2026
NOVATO, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2025 Impact Report , detailing the company's work on behalf of patients and families living with rare and [...]
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
08/07/2026
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)
08/07/2026
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days of Patent Term Adjustment Notice of allowance also received in a [...]
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
08/07/2026
The appointment follows New c elX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101 , providing a clear regulatory pathway toward clinical trials Dr. Ricordi to s upport a dvancement of New c elX's [...]
GeneCentric Launches ExpressCT Rewind™ to Unlock Gene Expression Insights from Existing Liquid Biopsy DNA Sequencing
08/07/2026
Retrospective fragmentomics capability lets biopharma and academic researchers extract a second dimension of biology from archived liquid biopsy DNA sequencing data DURHAM, N.C., July 08, 2026 (GLOBE NEWSWIRE) -- [...]

Pages